Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

Henri Roché, Hervé Curé, Louise Yelle et al.|Journal of Clinical Oncology|2007

Cited by 225